Institute of Health and Wellbeing

Publications

Recent publications involving the members of HEHTA are given below. Further details are available from individual web pages.

In press

2012

  • Craig P, Cooper C, Gunnell D, Haw S, Lawson K, Macintyre S, Ogilvie D, Petticrew M, Reeves B, Sutton M, Thompson S.  Using natural experiments to evaluate population health interventions: new Medical Research Council guidance.  Journal of Epidemiology and Community Health 2012;May 10 online first
  • Inglis SC, Lewsey JD, Chandler D, Byrne DS, Lowe GDO, MacIntyre K, on behalf of the Peripheral Artery Disease Project Advisory Group.  Sex-specific time trends in first admission to hospital for peripheral artery disease in Scotland 1991-2007.  British Journal of Surgery Society 2012;(online 7th Feb)
  • Shaw R, Gillies M, Barber J, MacIntyre K, Harkins C, Findlay IN, McCloy K, Gillie A, Scoular A, MacIntyre PD.  Pre-exercise screening and health coaching in the CHD secondary prevention: a qualitative study of the patient experiance.  Health Education Research 2012;advance access February 7th
  • Ul-Haq Z, Mackay DF, Fenwick E, Pell JP.  Impact of metabolic comorbidity on the association between body mass index and health-related quality of life: a Scotland-wide cross-sectional study of 5,608 participants.  BMC Public Health 2012;12:143
  • Watterson A, Little D, Young JA, Murray F, Doi L, Boyd KA, Azim E.  Scoping a public health impact assessment of aquaculture with particular reference to tilapia in the UK.  ISRN Public Health 2012(in press)

2011

  • Bauld L, Boyd KA, Briggs AH, Chesterman J, Ferguson J, Judge K, Hiscock R.  One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services.  Nicotine & Tobacco Research 2011;13(2):135-145
  • Barton P, Andronis L, Briggs A, McPherson K, Capewell S.  Effectiveness of cardiovascular disease prevention in whole populations: modelling study.  BMJ 2011;343
  • Bousquet J, Schunemann HJ, Bousquet PJ, Bachert C, Canonica GW, Casale TB, Demoly P, Durham S, Carlsen KH, Malling HJ, Passalacqua G, Simons FER, Anto J, Baena-Cagnani CE, Bergmann KC, Beiber T, Briggs AH, Brozek J, Calderon MA, Dahl R, Devillier P, Gerth van Wijk R, Howart P, Larenas D, Papadopoulos NG, Schmid-Grendelmeier P, Zuberbier T.  How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA2LEN statement.  Allergy 2011;66(6):765-774
  • Boyd KA, Briggs AH, Paul J, Iveson T, Midgely R, Harkin A, Bates G, Alexander L, Cassidy J.  Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting? Trials 2011;12(Suppl 1):A41
  • Boyd K, Briggs AH, Fenwick E, Norrie J, Stock S.  Power and sample size for cost-effectiveness analysis: fFN neonatal screening.  Contemporary Clinical Trials 2011;32:893-901
  • Brush J, Boyd K, Chappell F, Crawford F, Dozier M, Fenwick E, Glanville J, McIntosh H, Renehan A, Weller D, Dunlop M.  The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.  Health Technology Assessment 2011;15(35)ISSN 1366-5278
  • Caskey FJ, Kramer A, Elliott RF, Stel VS, Covic A, Cusumano A, Geue C, Macleod AM, Zwinderman AH, Stengel B, Jager KJ.  Global variation in renal replacement therapy for end-stage renal disease.  Nephrol Dial Transplant 2011;Advance access pub Jan 18
  • Chew C, Craig L, Edwards R, Moss J, O'Dwyer PJ.  Saftey and afficacy of percutaneous vertebroplasty in malignancy: a systematic review.  Clinical Radiololgy 2011;66:63-72
  • Clark P, Wu O.  ABO blood groups and thrombosis: a causal association but is there value in screening?  Future Cardiololgy 2011;7(2)191-201
  • Craig LE, Wu O, Bernhardt J, Langhorne P.  Predictors of poststroke mobility: systematic review.  International Journal of Stroke 2011;6:321-327
  • Craig P, Cooper C, Gunnell D, Haw S, Lawson K, Macintyre S, Ogilive D, Petticrew M, Reeves B, Sutton M, Thompson S.  Using natural experiments to evaluate population health interventions. Glasgow: Medical Research Council 2011;Jul 11:1-29
  • Cummins E, Asseburg C, Punekar YS, Shore E, Morris J, Briggs A, Fenwick E.  Cost-effectiveness of infliximab for the treatment of active and progressive psoriatic arthritis.  Value in Health 2011;14:15-23
  • Geue C, Lewsey J, Lorgelly P, Govan L, Hart C, Briggs A.  Spoilt for choice: implications of using alternative methods of costing hospital episode statistics.  Health Economics 2011;published on line
  • Govan L, Wu O, Briggs A, Colhoun HM, MacKnight JA, Morris AD, Pearson DWM, Petrie JR, Sattar N, Wild SH, Lindsay RS on hehalf of the Scottish Diabetes Research Network Epidemiology Group.  Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.  Diabetologia 2011;54:2000-2008
  • Jackson CE, MacDonald MR, Petrie M, Solomon SD, Pitt B, Latini R, Maggioni AP, Smith BA, Prescott MF, Lewsey J, McMurray JJV, and for the ALiskeren Observation of heart Failure Treatment (ALOFT) investigators.  Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment Study. European Journal of Heart Failure  2011;advance access published April 1
  • Klemp M, Fronsda KB, Facey K.  What principles should govern the use of managed entry agreements.  International Journal of Technology Assessment in Health Care 2011;27(1):77-83
  • Macpherson KJ, Lewsey JD, Jhund PS, Gillies M, Chalmers JWT, Redpath A, Briggs A, Walters M, Langhorne P, Capewell S, McMurray JJV, MacIntyre K.  Trends in incidence and in short term survivial following a subarachnoid haemorrhage in Scotland, 1986-2005: a retrospective cohort study.  BMC Neurology 2011;11:38
  • McLean RC, Briggs AH, Slack R, Zamvar V, Berg GA, El-Shafei H, Oldroyd KG, Pell JP.  Perioperative and long-term outcomes following aortic valve replacement: a population cohort study of 4124 consecutive patients.  European Journal of Cardio-thoracic Surgery 2011;Article in press
  • Mihaylova B, Briggs A, O'Hagan A, Thompson SG.  Review of statistical methods for analysing healthcare resources and costs.  Health Economics 2011;20(8):897-916
  • Moss JG, Cooper KG, Khaund A, Murray LS, Murray GD, Wu O, Craig LE, Lumsden MA.  Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results.  BJOG 2011;published online 12th April
  • Price MJ, Welton NJ, Briggs AH, Ades AE.  Model averaging in the presence of structural uncertainty about treatment effects: Influence on treatment decision and expected value of information.  Value in Health 2011;14:205-218
  • Postmus D, van Veldhuisen DJ, Jaarsma T, Luttik ML, Lassus J, Mebazaa A, Nieminen MS, Harjola V-P, Lewsey J, Pinto YM, Buskens E, Hillege HL.  The COACH risk engine: a multi-state model for predicting and survival hsopitalization in patients with heart failure.  European Jouranl of Heart Failure 2011(in press)
  • Roberts NJ,  Smith SF, Partridge MR.  Why is spirometry underused in the diagnosis of the breathless patient: a qualitative study.  BMC Pulmonary Medicine 2011;11:37
  • Shaw R, Fenwick E, Baker G, McAdam C, Fitzsimons C, Mutrie N.  'Pedometers cost buttons': the feasibility of implementing a pedometer based walking programme within the community.  BMC Public Health 2011;11:200
  • MacMillan F, Fitzsimons C, Black K, Granat MH, Grant MP, Grealy M, Macdonald H, McConnachie A, Rowe DA, Shaw R, Skelton DA, Mutrie N.  West End Walkers 65+: A randomised controlled trial of a primary care-based walking intervention for older adults: Study rationale and design.  BMC Public Health 2011;11:120
  • Starkie HJ, Briggs AH, Chambers MG, Jones P.  Predicting EQ-5D values using the SGRQ.  Value in Health 2011;14:354-360
  • Toerien M, Shaw R, Duncan R, Reuber M.  Offering patients choices: A pilot study of interactions in the seizure clinic.  Epilepsey & Behaviour 2011;20(2):312-320
  • Wellwood I, Wu O, Langhorne P, McKevitt C, Di Carlo A, Rudd AG, Wolfe CDA.  Developing a tool to assess quality of stroke care across European populations: The EROS quality assessment tool.  Stroke 2011;published online 7th April

2010

  • Adachi JD, Adami S, Gehlbach S, Anderson FA, Boonen S, Chapurlat RD, Compston JE, Cooper C, Delmas P, Diez-Perez A, Greenspan SL, Hooven FH, LaCroix AZ, Lindsay R, Netelenbos C, Wu O, Pfeilschifter J, Roux C, Saag KG, Sambrook PN, Silverman S, Siris ES, Nika G, Watts NB.  Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women.  Mayo Clin Pro 2010(published online July 15)
  • Alcorn N, Tierney A, Wu O, Gilmour H, Madhok R.  Impact of anti-tumour necrosis factor therapy on the weight of patients with rheumatoid arthritis.  Annals of the Rheumatic Diseases 2010;(published online April 13)
  • Bauld L, Boyd KA, Briggs AH, Chesterman J, Ferguson J, Judge K, Hiscock R.  One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services.  Nicotine & Tobacco Research Online 31/12/2010
  • Boyd KA, Fenwick E, Briggs A.  Using an iterative approach economic evaluation in the drug development process.  Drug Development Research 2010;71(8):470-477
  • Briggs A.  Transportability of comparative effectiveness and cost-effectiveness between countries.  Value in Health 2010;13:S22-S25
  • Briggs A, Ritchie K, Fenwick E, Chalkidou K, Littlejohns P.  Access with evidence development in the UK: past experience, current initiatives and future potential.  PharmacoEconomics 201028(2):163-170
  • Campbell H, Gray AM, Harris AL, Briggs AH, Taylor MA.  Estimation and exteranl validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.  British Journal of Cancer 2010;103(6):776-786
  • Caskey FJ, Stel VS, Elliott RF, Jager KJ, Covic A, cusumano A, Geue C, Kramer A, Stengel B, MacLeod AM.  The EVEREST study: an international collaboration.  Nephrololgy Dialysis Transplantaion Plus 2010;3(1):28-36
  • Clark P, Wu O, Greer IA, Lowe GDO.  Venous thrombosis prevention - more than just guidelines.  British Journal of Haematology 2010;149:50-54
  • Craig LE, Bernhardt J, Langhorne P, Wu O.  Early mobilization after stroke: an example of an individual patient data meta-analysis of a complex intervention.  Stroke 2010;41:2632-2636
  • Dolan GP, Stone DH, Briggs AH.  A systematic review of continuous performance task research in children prenatally exposed to alcohol.  Alcohol and Alcoholism 201045(1):30-38
  • Facey K, Boivin A, Gracia J, Hansen HP, Lo Scalzo A, Mossman J, Single A.  Patients perspectives in health technology assessment: A route to robust evidence and fair deliberation.  International Journal of Technology Assessment in Health Care 2010;26(3):334-340
  • Fronsda KB, Facey K.  Health technology assessment to optimize health technology utilization: Using implementaion initiatives and monitoring processes.  International Journal of Technology Assessment in Health Care 2010;26(3):309-316
  • Govan L, Ades AE, Weir CJ, Welton NJ, Langhorne P.  Controlling ecological bias in evidence synthesis of trials reporting on collapsed and overlapping covariate categories.  Statist Med 2010;29:1340-1354
  • Harkins C, Shaw R, Gillies M, Sloan H, MacIntyre K, Scoular A, Morrison C, Mackay F, Cunningham H, Docherty P, MacIntyre P, Findlay I.  Overcoming barriers to engaging socio-economically disadvantaged populations in CHD primary preventions: a qualitative study.  BMC Public Health 2010;10:391
  • Hollingworth W, Campbell JK, Kowalski J, Ravelo A, Girod I, Briggs A, Sullivan SD.  Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomes.  Quality of Life Research 2010;19(3):323-33
  • Johnston KM, Levy AR, Lima VD, Hogg RS, Tyndall MW, Gustafson P, Briggs A, Montaner JS.  Expanding access to HARRT: a cost-effective approach for treating and preventing HIV.  Aids 2010;24(12):1929-1935
  • Lawson KD, Fenwick EAL, Pell ACH, Pell JP.  Comparison of mass and targeted screening strategies for cardiovascular risk: simulation of the effectiveness, cost-effectivenees and coverage from a cross-sectional survey of 3,921 people.  Heart 2010;96:208-212
  • Levy AR, Mitton C, Johnston K, Harrigan B, Briggs AH.  International comparison of comparative effectiveness research in five jurisdictions: insights for the US.  Pharmacoeconomics 2010;28(10):813-830
  • Lewsey J, Pardeep JS, Gillies M, Chalmers JWT, Redpath A, Briggs A, Walter M, Langhorne P, Capewell S, McMurray JJV, MacIntyre K.  Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland.  BMC Medicine 2010;8:23
  • Lorgelly P, Lawson KD, Fenwick EAL, Briggs AH.  Outcome measurement in economic evaluations of Public Health interventions: a role for the capability approach.  International Journal of Environmental Research and Public Health 2010;7:2274-2289
  • Lorgelly P, Briggs A, Wedel H, Dunselman P, Hjalmarson A, Kjekshus J, Waagstein F, Wikstrand J, Janosi A, van Veldhuisen DJ, Barrios V, Fonseca C, McMurray JJV, on behalf of the CORONA Study Group.  An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial.  European Journal of Heart Failure 2010;12:66-74
  • MacDonald MR, Eurich DT, Majumdar SR, Lewsey JD, Bhagra S, Jhund PS, Petrie MC, McMurray JJV, Petrie JR, McAlister FA.  Treatment of type 2 diabetes and outcomes in paitents with heart failure: a nested case-control study from the U.K. General Practice Research Database.  Diabetes Care 2010;33(6):1213-1218
  • Walker S, Mason AR, Claxton K, Cookson R, Fenwick E, Fleetcroft R, Sculpher M.  Value for money and the quality and outcomes framework in primary care in the UK NHS.  British Journal of General Practice 2010;60(574)e213-e220(8)
  • Young JA, Little DC, Watterson A, Murray F, Boyd K, Leschen W, Kodithuwakku S.  Growing Green: the emergent role of non-tilapia attributes in marketing tilapia.  Aquaculture Economics & Management 2010;14(1)63-79

2009

  • Barton GR, Briggs AH, Fenwick EAL.  Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI).  Volume in Health 2009;11(5):886-897
  • Bauld L, Briggs AH, Boyd K, Chesterman J, Ferguson J, Judge K, Wilson M.  Comparing models of smoking treatment in Glasgow:  Final report. Online Feb 2009
  • Belton B, Little D, Grady K.  Is responsible aquaculture sustainable aquaculture? WWF and the eco-certification of tilapia.  Society & Natural Resources 2009;22(9):840-855
  • Boyd KA, Briggs AH. Cost effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow.  Addiction 2009;104:317-325
  • Briggs A, Glick H, Lozano-Ortega G, Spencer M, Calverley P, Jones P, Vestbo.  Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study.  European Respiratory Journal 2009(on line Aug 29)
  • Briggs A, Wild D, Lees M, Reaney M, Dursden S, Parry D, Mukhurjee J.  Impact of schizophrenia and schizophrenia-related adverse events on quality of life: direct utility elicitation.  Health and Quality of Life Outcomes 2009;6(105):1-9
  • Geue C, Skatun D, Sutton M.  Economic influences on GP's decisions to provide out-of-hours care.  British Journal of General Practice 2009;59(558)e1-e7
  • Govan L, Langhorne P, Weir CJ.  Categorising stroke prognosis using different stroke scales.  Stroke 2009 August (Online Access)
  • Jacobs-van der Bruggen MAM, van Baal PH, Hoogenveen RT, Feenstra TL, Briggs AH, Lawson K, Feskens E, Baan CA.  Cost-effectiveness of lifestyle modification in diabetes patients.  Diabetes Care  2009;32(8);1453-1458
  • Kerr G, Ray G, Wu O, Stott DJ, Langhorne P.  Elevated troponin after stroke: a systematic review.  Cerebrovascular disease 2009;28:220-226
  • Lewsey JD, Jhund PS, Gillies M, Chalmers JWT, Redpath A, Kelso L, Briggs A, Walters M, Langhorne P, Capewell S, McMurray JJV, MacIntyre K.  Age- and sex-specific trends in fatal incidence and hospitalized incidence of Stroke in Scotland, 1986 to 2005.  Circ Cardiovasc Qual Outcomes  2009;2:475-483
  • Lewsey JD, Gillies M, Jhund PS, Chalmers JWT, Redpath A, Briggs A, Walters M, Langhorne P, Capewell S, McMurray JJV, MacIntyre K. Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005. Stroke 2009;Feb10:1-6 Online
  • Levy AR, Szabo S, Briggs A, Pleil A, Davie A, Zlateva G, Javitt J.  Joint assessment of intended and unintended effects of medications: an example using vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration.  Journal of Opthalmology 2009;(published online 16 Feb 2010)
  • Levy A, Harrigan B, Johnston K, Briggs A.  Comparative effectiveness research through the looking glass.  Medical Decision Making 2009;29(6):NP6-NP8
  • Mihaylova B, Briggs A, Hlatky M, Armitage J, Parish S, Gray A, Collins R.  Statin cost-effectiveness in the United States for people at different vascular risk levels.  Circ Cardiovasc Qual Outcomes 2009;2(2):65-72
  • Wu O, Levy AR, Briggs A, Lewis G, Jardine A.  Acute rejection and chronic nephropathy: a systematic review of the literature.  Transplantation 2009;87(9):1330-1339
  • Wu O.  Oral contraceptives and venous thromboebolism: identifying the safest option.  Expert Reviews 2009;7(12):1513-1516

2008

  • Briggs AH, Spencer M, Wang H, Mannino D, Sin D. Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease. Archives in Internal Medicine 2008;168:71-79
  • Clark P, Walker ID, Govan L, Wu O, Greer IA.  The GOAL study: a prospective examination of the impact of Factor V Leiden and ABO blood groups on haemorrhagic and thrombotic pregnancy outcomes. British Journal of Haematology 2008;140:236-240
  • Claxton K, Briggs AH, Buxton MJ, Clyer AJ, McCabe C, Walker S, Sculpher MJ. Value based pricing for NHS drugs: an opportunity not to be missed? BMJ 2008;336:251-254
  • Coast J, Smith R, Lorgelly PK.  Should the capability approach be applied in health economics? Health Economics 2008;17:667-670
  • Collins R, Fenwick E, Trowman R, Perard R, Norman G, Light K, Birtle A, Palmer S, Riesma R. A sytematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination iwth prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer.  Health Technology assessment 2008;11:1-179
  • Craig LE, Smith L.  The interaction between policy and education using stroke as an example.  Nurse Education Today 2008;28:77-84
  • Eckermann S, Briggs A, Willan A.  Health technology assessment in the cost-disutility plane.  Medical Decision Making 2008;28:172-181
  • Fenwick E, Claxton K, Sculpher M. The value of implementaion and the value of information: combined and uneven development.  Medical Decision Making 2008;28:21-32
  • Fenwick E, Marshall DA, Blackhouse G, Vidaillet H, Slee A, Shemanski L, Levy AR. Assessing the impact of censoring of costs and effects on health-care decision-making: an example using the atrial fibrillation follow-up investigation of rhythm managment (AFFIRM) study.  Value in Health 2008;11:367-375
  • Fitzsimons C, Baker G, Wright A, Nimmo M, Ward Thompson C, Lowry R, Millington C, Shaw R, Fenwick E, Ogilive D, Inchley J, Foster C.  The "walking for wellbeing in the West" randomised controlled trial of a pedometer-based walking programme in combination with physical activity consultation with 12 month follow-up: rationale and study design.  BMC Public Health 2008;8(1):259
  • Govan L, Weir C, Langhorne P (for the stroke unit trialists' collaboration).  Organized inpatient (Stroke Unit) care for stroke.  Stroke 2008;39(8):2402-2403
  • Hirst A, Dutton S, Wu O, Briggs A, Edwards C, Waldenmaier L, Maresh M, Nicholson A, McPherson K.  The HOPEFUL Study: a multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation (UAE) for the treatment of symptomatic uterine fibroids.  Health Technology Assessment 2008;12(5):1-248
  • Hoomans T, Fenwick EA, Palmer S, Claxton K.  Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer.  Value in Health 2008;12(2)315-324
  • Iturriza Gómara M, Simpson R, Perault AM, Redpath C, Lorgelly PK, Joshi D, Mugford M, Hughes CA, Dalrymple J, Gray J.  “Structured surveillance of infantile gastroenteritis in East Anglia, UK: incidence of infection with common viral gastroenteric pathogens”. Epidemiology and Infection 2008;136(1):23-33
  • Levy AR, Kowdley K, Iloeje UH, Tafesse E, Mukherjee J, Gish R, Bzowej N, Briggs AH.  The impact of chronic hepatitis B disease progression on quality of life: a mulinational study of health state preferences from infected and uninfected persons.  Value in Health 2008;11(3):527-538
  • Little DC, Murray FJ, Azim E, Leschen W, Boyd K, Watterson A, Young JA.  Options for producing a warm-water fish in the UK: limits to "Green Growth"? Trends in Food Science & Technology 2008;19:255-264
  • Lorgelly PK, Joshi D, Iturriza Gómara M, Flood C, Hughes CA, Dalrymple J, Gray J, Mugford M.  “Infantile gastroenteritis in the community: a cost of illness study”. Epidemiology and Infection 2008;136(1)34-43
  • Lorgelly PK, Joshi D, Iturriza Gómara M, Gray J, Mugford M.  “Exploring the Cost-effectiveness of an Immunisation Programme for Rotavirus in the UK”. Epidemiology and Infection 2008;136(1):44-55
  • Lorgelly PK, Lindley J.  “What is the relationship between income inequality and health? Evidence from the BHPS”. Health Economics 2008;17(2):249-265
  • Smith LN, Craig LE, Weir CJ, McAlpine CH.  The evidence-base for stroke education in care homes.  Nurse Education Today 2008;28:829-840
  • Wu O, Clark P.  ABO(H) blood groups and pre-eclampsia : a sytematic review and meta-analysis.  Thrombosis and Haemostasis 2008;100:469-474
  • Wu O, Bayoumi N, Vickers MA, Clarke PM.  ABO(H) blood groups and pre-eclampsia: a systematic review and meta-analysis.  Journal of Thrombosis and Haemostasis 2008;6:62-69
  • Smith LN, Craig LE, Weir CJ, McAlpine CH.  Stroke education for healthcare professionals: making it fit for a purpose.  Nurse Education Today 2008;28:337-347  
  • Starkie H, Briggs A, Chambers M. Pharmacoeconomic issues in management of COPD. International Journal of COPD 2008;3:71-88
  • Watterson A, Little D, Young JA, Boyd K, Azim E, Murray F.  Towards integration of environmental and health impact assessments for wild capture fishing and farmed fish with particular reference to public heatlh and occupational health dimensions.  International Journal of Environmental Research and Public Health 2008;5:258-277

2007

  • Asseberg C, Bravo Y, Palmer S, Fenwick E, de Belder M, Abrams K, Sculpher M. Assessing the effectiveness of primary angioplasty compared to thrombolysis and its relationship to time delay: a Bayesian evidence synthesis.  Heart 2007;93:1244-50
  • Briggs A , Mihaylova B, Sculpher M, Hall A, Wolstenholm J, Simoons M, Deckers J, Ferrari R, Remme W, Betrand M, Fox K.  The Cost-effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA Study.  Heart 2007; 93 :1081-1086
  • Campbel H, Briggs AH, Buxton MJ, Kim L, Thompson S. The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm. Journal of Health Services & Research Policy 2007;12:11-17
  • Clark P, Walker ID, Govan L, Wu O, Greer IA.  The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrahgic and thrombotic pregnancy outcomes.  British Journal of Haematology 2007;140(2):236-240
  • Collins R, Fenwick E, Trowman R, Perard R, Norman G, Light K, Birtle A, S Palmer and R Riemsma. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer. Health Technol Assess 2007;11(iii-iv, xv-xviii):1-179
  • Culyer AJ, McCabe CJ, Briggs AH , Claxton K, Buxton M, Akehurst RL, Sculpher M, Brazier J.  Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence.  Journal of Health Services Research & Policy 2007; 12: 56 - 58
  • Edwards D, Moss JG, Lumsden MA, Wu O, Murray LS, Twaddle S, Murray GD for the REST Investigators.  Uterine-artery embolisation versus surgery for symptomatic uterine fibroids.  New England Journal of Medicine 2007;356:360-70
  • Fenwick E, Briggs A. Cost-effectiveness acceptability curves in the dock: Case not proven? Medical Decision Making  2007;27(2):93-95
  • Govan L, Langhorne P, Weir C (for the stroke unit trialists collaboration).  Does the prevention of complications explain the survival benefit of organized inpatient (Stroke Unit) care?. Further analysis of a systematic review.  Stroke 2007;38(9):2536-2540
  • Hanson M, Murray K, Wu O.  Evaluation of OHSxtra: a pilot occupational health case management programme within NHS Fife and NHS Lanarkshire.  Produced for NHSScotland June 2007
  • Kim L, Thompson S, Briggs A , Buxton M, Campbell H.  Modelling the long-term cost-effectiveness of screening for abdominal aortic aneurysms.  Journal for Medical Screening 2007;14(1):46-52
  • Luc G, Ades AE, Sutton AJ, Cooper NJ, Briggs AH , Caldwell DM.  Meta-analysis of mixed treatment comparisons at multiple follow-up times.  Statistics in Medicine 2007;26:3681-1699
  • Madhok R, Wu O.  Systemic Lupus Erythematosus.  In: BMJ Clinical Evidence.  BMJ Publishing Group Limited 2007
  • Ossa DF, Briggs AH, McIntosh E, Cowell W, Littlewood T, Sculpher MJ. Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods.  PharmacoEconomics 2007;25:223-237
  • Shaw R.  '"It's your body, your baby, your birth": planning and achieving a home birth'. Feminism and Psychology 2007;17(4):565-570
  • Shaw R, Kitzinger C.  Memory in interaction: an analysis of repeat calls to a Home Birth Helpline. In the special edition of Research on Language and Social Interaction, 'Calling for Help'. Research on Language and Social Interaction 2007;40(1):117-144
  • Shaw R, Kitzinger C. Problem presentation and advice-giving on a Home Birth Helpline: A feminist conversation analytic study.  Feminism and Psychology 2007;17(2):203-213
  • Stroke unit trialists' collaboration.  Organised inpatient (stroke unit) care for stroke.  Cochrane Database of Systematic Reveiws 2007: issue 4
  • Vergel YB, Palmer S, Asseburg C, Fenwick E, de Belder M, Abrams K, Sculpher MJ. Is primary angioplasty cost effective in the UK? results of a comprehensive decision analysis.  Heart 2007;93:1238-1243
  • Wu O, Briggs A, Dutton S, Hirst A, Maresh M, Nicholson A, McPherson K.  Uterine artery embolisation or hysterectomy for the treatment of symptomatic uterine fibroids: a cost-utility analysis of the HOPEFUL study.  British Journal of Obstetrics and Gynaecology 2007;114:1352-1362
  • Wu O, Briggs A, Dutton S, Hirst A, Maresh M, Nicholson A, McPherson K.  Uterine artery embolisation or hysterectomy for the treatment of symptomatic uterine fibroids: a cost-utility analysis of the HOPEFUL study.  British Journal of Obstetrics and Gynaecology 2007;114:1352-1362
  • Wu O, Greer IA.  Is screening for thrombophilia cost effective?  Current Opinion in Hematology 2007;14:500-503.
  • Wu O, Maddox J, Clark P on behalf of TREATS study group.  Stock-take of guidance and audit relating to venous thromboembolism prevention and treatment in NHSScotland.  Produced for NHS QIS June 2007 

 2006

  • Bachmann, MO, R Reading, C Husbands, M O'Brien, J Thoburn, I Shemilt, J Watson, N Jones, R Haynes, M Mugford and the NECT team.  "What are children's trusts? Early findings from a national survey."  Child: Care, Health and Development 2006;32(2):137-146
  • Briggs A , Bousquet J, Wallace M, Busse WW, Clark TJH, Pederson SE, Bateman E.  Cost-effectiveness of asthma control: an economic appraisal of the GOAL study.  Allergy 2006;61:531-536
  • Briggs AH, Levy AR. Pharmacoeconoics and pharmacoepidemiology-curious bedfellows or a march made in heaven? PharmacoEconomics 2006;24:1079-1086
  • Briggs A , Lozano-Ortega G, Spencer S, Bale G, Spencer M, Burge S.  Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease.  Value in Health 2006;9(4):227-235
  • Collins R, Trowman R, Norman G, Light K, Birtle A, Fenwick E , Palmer S and Riemsma R. A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer. British Journal of Cancer 2006;95:457-462.
  • Deckers JW, Goedhart DM, Boersma E, Briggs A , Bertrand M, Ferrari R, Remme WJ, Fox K, Simoons ML.  Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk.  European Heart Journal 2006;27:796-801
  • Fenwick E, Marshall DA, Levy AR, Nichol G. Using and interpreting cost-effectiveness acceptability curves: An example using data from a trial of management strategies for atrial fibrillation. BMC Health Services Research 2006;6:52
  • Fenwick E, Palmer S, Claxton K, Sculpher M, Abrams K and Sutton A. An iterative Bayesian approach to health technology assessment: Application to a policy of pre-operative optimisation for patients undergoing major elective surgery. Medical Decision Making 2006;26(5):480-496
  • Greer IA, Wu O.  More on "Universal Versus Selected" screening for thrombophilia: the hidden costs of false-positive diagnosis - response to favaloro and keeling.  British Journal of Haematology 2006;134:241
  • Lorgelly, PK.  "Gender inequalities in health and health care: What do we know so far", in W Ernst and U Bohle (eds), Naturbilder und Lebensgrundlagen: Konstruktionen von Geschlecht. Internationale Frauen- und Genderforschung in Niedersachsen. Teilband 1. Lit Verlag, Munster. 2006
  • Madhok R, Wu O, McKellar G, Singh G.  Non-steroidal anti-inflammatory drugs: changes in prescribing may be warranted [Editorial].  Rheumatology 2006;45:1458-1460
  • Mihaylova B, Briggs A , Armitage J, Parish S, Gray A, Collins R for the Heart Protection Study Collaborative Group.  Lifetime cost-effectiveness of simvastatin in a range of risk and age groups derived from a randomised trial of 20 536 people.  British Medical Journal 2006;333(7579):1145-1149. 
  • Mujica Mota, R, PK Lorgelly, M Mugford, T Toroyan, A Oakley, G Laing and I Roberts.  "Out of home day care for families living in a disadvantaged area of London: economic evaluation alongside a RCT".   Child: Care, Health and Development  2006;32(3):287-302
  • Singh G, Wu O, Langhorne P, Madhok R.  Risk of acute myocardial infarction with non-selective non-steroidal anti-inflammatory drugs: a meta-analysis.  Arthritis Research & Therapy 2006;8:R153 - advanced access.
  • van Damme, P, M van der Wielen M, F Ansaldi, D Desgrandchamps, JD Domingo, FG Sanchez, J Gray, M Haditsch, K Johansen, PK Lorgelly, M Lorrot, N Parez, V Reschke, M Rose. "Rotavirus vaccines: considerations for successful implementation in Europe".  The Lancet Infectious Diseases 2006;6(12):805-12
  • Wu O, Greer IA, on behalf of the TREATS Study Group.  More on universal versus selected screening for thrombophilia: the hidden costs of false-positive diagnosis - response [Letter].  Br J Haematol 2006;134:241
  • Wu O, Langhorne P.  The challenge of acute stroke management in the UK: does telemedicine offer a solution?  International Journal of Stroke 2006;1:201-207
  • Wu O, Robertson L, Twaddle S, et al.  Screening for thrombophilia in high-risk situations: a systematic review and cost-effectiveness analysis.  The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study.  Health Technol Assess 2006;10(11)
  • Zatarain E, Wu O, Singh G.  NSAIDs - COX-2 inhibition.  In: Madhok R, Capell HA, Luthra HS, editors.  The year in rheumatic disorders volume 5.  Oxford: Clinical Publishing 2006